Oriola KD Oyj operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Oriola KD Oyj with three other
drug stores in Europe:
sales of 8.46 billion Polish New Zlotys [US$2.15 billion]
of which 69%
was Wholesale Trade),
(6.95 billion Polish New Zlotys [US$1.77 billion]
of which 100%
was Pharmaceutical Wholesale), and
based in Poland
(5.91 billion Polish New Zlotys [US$1.50 billion]
of which 102%
During the year ended December of 2015, sales at
Oriola KD Oyj were 1.63 billion Euro (US$1.79 billion).
a very small
increase of 0.9%
versus 2014, when the company's sales were 1.61 billion Euro.
Despite this increase, sales are still
below the level achieved in 2013, when Oriola KD Oyj
reported sales of 2.60 billion Euro.
Sales of Pharmaceutical Trade Sweden saw an increase
1.2% in 2015, from
1.18 billion Euro to 1.19 billion Euro.